Propella Therapeutics, Inc. Email Format

PharmaceuticalsNorth Carolina, United States2-10 Employees

Propella Therapeutics, Inc. is a privately held development-stage pharmaceutical company focused on bringing to market drugs that leverage an active ingredient with a known mechanism of action. Based in Pittsboro, North Carolina, the company operates within the pharmaceutical manufacturing industry and concentrates on therapies in development for cancer, including prostate cancer, as evidenced by its work on a next-generation androgen biosynthesis inhibitor. With a small team, Propella collaborates on partnerships and licensing activities to advance its clinical programs toward potential commercialization. A notable recent development is the acquisition of Propella by Astellas Pharma in late 2023, following Propella’s ongoing collaboration and development efforts in its pipeline. The company has previously announced strategic licensing arrangements and partnerships to develop and commercialize its compounds in key markets.

Sign up for free to view info

Company overview Employee directory